IN-Person

IN-Person

IN-Person

Broughton

Broughton is an independent life sciences contract research organization serving a global roster of clients from Europe, North America, the Middle East, Asia, and Australia. We offer high-quality analytical testing and E&L services integrated with scientific consultancy and regulatory compliance across all stages of the pharmaceutical, nicotine, and cannabinoid product lifecycle.

With over 15 years of scientific experience and a world-leading team of scientific and regulatory consultants, we support partners in bringing innovative products to market to improve societal health and well-being.

Our in-house laboratory testing facilities are GMP and GLP compliant and regularly inspected by the Medicines and Healthcare products Regulatory Agency (MHRA), US Food and Drug Administration (FDA), and United Kingdom Accreditation Service (UKAS). The foundation of the Broughton business is excellence in analytical testing, working with partners to accelerate their innovative products to market, and developing new business services to address unmet needs within the life sciences industry.

INTERTEK

Intertek is an analytical contract organization with more than 45’000 employees offering its services to CDMOs/CMOs, pharma and biopharmaceutical companies under GMP (FDA), ISO and GLP requirements. Intertek is supporting customers in the development of drug products through all clinical phases and a wide range of applications worldwide.

The focus of Intertek (Schweiz) AG is on extractable & leachable studies, which we are enlarging continuously by a multi-million-dollar investment started in 2022.

In addition, we are offering some supplemental studies as glass delamination studies, particle/impurity investigations, NMR related services under GMP and nitrosamine quantification.

IN-Person

IN-Person

WuXi AppTec

WuXi AppTec has a state-of-the-art analytical chemistry laboratory, along with experienced scientists, chemists, and toxicologists, located in St. Paul, Minnesota. Our extractables / leachables team partners with our customers to support product safety with regulatory consulting, pre-clinical testing, and post-commercialization product testing support.

Our regulatory and technical experience with active participation and/or leadership on global committees allows us to anticipate regulatory trends. Our chemistry program driving principle is complete chemical characterization. This is our standard of practice as our chemists work closely with our toxicologists to provide the most mass-accurate data and virtually no unknowns in our chemistry reports.

 Extractables/Leachables Chemistry Business

WuXi AppTec has a state-of-the-art analytical chemistry laboratory, along with experienced scientists, chemists, and toxicologists, located in St. Paul, Minnesota. Our extractables/leachables team partners with our customers to support product safety with regulatory consulting, pre-clinical testing, and post-commercialization product testing support. Our regulatory and technical experience with active participation and/or leadership on global committees allows us to anticipate regulatory trends. Our chemistry program driving principle is complete chemical characterization. This is our standard of practice as our chemists work closely with our toxicologists to provide the most mass-accurate data and virtually no unknowns in our chemistry reports.

ONdrugDelivery

ONdrugDelivery provides 30,000 readers throughout global pharma/biopharma, with the latest, most pertinent industry information and intelligence about the drug delivery-related ideas, technologies, services and products the sector is developing. Established in 2004, and trusted throughout the industry for its high quality contributions from leading drug delivery experts, ONdrugDelivery is a must for pharma / biotech industry professionals who need to know what’s going on in drug delivery.

Subscribe online today to the print or free digital edition: ondrugdelivery.com/subscribe

PharmaCircle

PharmaCircle is a leading information provider to the pharmaceutical, biotechnology and device industries and scientific community – publishing the Drug Delivery & Formulation Newsletter, and providing through its subscription database pipeline and product intelligence on drugs and biologics, expert analysis of drug delivery technologies and devices, extensive coverage of medical diagnostics, and detailed reports on emerging stage and commercial life sciences companies and suppliers from around the world.